The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma

被引:0
|
作者
Reichert, TE
Scheuer, C
Day, R
Wagner, W
Whiteside, TL
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
[2] Univ Mainz, Dept Oral & Maxillofacial Surg, D-6500 Mainz, Germany
[3] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA
关键词
oral carcinoma; biomarkers; survival; dendritic cells; zeta chain; T lymphocytes;
D O I
10.1002/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.3.CO;2-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Dendritic cells (DCs) are antigen-presenting cells with a unique ability to cross prime T cells and generate strong antitumor responses. This study evaluates the presence and prognostic significance of DCs as well as functional T cells, which accumulate in the microenvironment in patients with oral squamous cell carcinoma (OSCC). METHODS, Immunohistochemistry for S-100 positive or p55 positive DCs and for T-cell receptor (TcR)-associated zeta -chain expression in tumor-infiltrating lymphocytes (TILs) was performed in 132 paraffin embedded specimens from patients with primary OSCC. The median clinical follow-up for the patients was 50 months. The numbers of intratumoral DCs or TILs expressing the zeta chain were determined microscopically and compared with clinical and pathohistologic prognostic parameters, including disease stage, T stage or tumor grade, lymph node involvement, as well as disease free survival and overall survival. RESULTS. Immunostaining identified DCs in the epithelial compartment of the tumors (S-100 positive) as well as interdigitating reticular DCs (p55 positive) in peritumoral areas. Based on S-100 staining, intratumoral DC infiltrates were low (< 10 DCs per high-power held [HPF]) in 20% of OSCC specimens, intermediate (10-20 DCs per HPF) in 42% of OSCC specimens, and high (> 20 DCs per HPF) in 37% of OSCC specimens. The number of S-100 positive DCs was positively and significantly correlated with that of p55 and of TILs with normal zeta -chain expression. A low number of infiltrating S-100 positive DCs was more predictive of poor survival (hazard ratio, 7.95) than lymph node involvement (hazard ratio, 3.36) or late T stage (hazard ratio, 2.92). A significant but weaker association of p55 positive DC infiltration with survival was observed. Low density of DCs and low or absent expression of the zeta chain in TILs correlated with each other and predicted the poorest survival and the greatest risk. CONCLUSIONS. The number of DCs infiltrating the tumor is a highly significant prognostic parameter in patients with OSCC. Furthermore, the absence or paucity of DCs is strongly linked to abnormalities in the TcR-associated zeta chain in TILs, The two biomarkers, zeta -chain expression in TILs and the number of S-100+ DCs in the tumor, independently predict overall survival, disease free survival, and time to disease recurrence in patients with OSCC. Cancer 2001;91:2136-47. (C) 2001 American Cancer Society.
引用
收藏
页码:2136 / 2147
页数:12
相关论文
共 50 条
  • [1] Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
    Reichert, TE
    Day, R
    Wagner, EM
    Whiteside, TL
    CANCER RESEARCH, 1998, 58 (23) : 5344 - 5347
  • [2] Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms
    Werner, Wiebke
    Detjen, Katharina
    Bruneau, Alix
    Lurje, Isabella
    Nestel, Natalie
    Jann, Henning
    Tacke, Frank
    Wiedenmann, Bertram
    Roderburg, Christoph
    Hammerich, Linda
    ENDOCRINE-RELATED CANCER, 2023, 30 (07)
  • [3] Intratumoral plasmacytoid dendritic cells and T cells associate with increased survival in patients with follicular lymphoma (FL)
    Butsch, R.
    Schaerer, S.
    Korol, D.
    Levi, E.
    Renner, C.
    Probst-Hensch, N.
    Moch, H.
    Kurrer, M.
    LABORATORY INVESTIGATION, 2008, 88 : 247A - 247A
  • [4] Intratumoral plasmacytoid dendritic cells and T cells associate with increased survival in patients with Follicular lymphoma (FL)
    Butsch, R.
    Schaerer, S.
    Korol, D.
    Levi, E.
    Renner, C.
    Probst-Hensch, N.
    Moch, H.
    Kurrer, M.
    MODERN PATHOLOGY, 2008, 21 : 247A - 247A
  • [5] Characterization of peripheral and intratumoral dendritic cells in patients with hepatocellular carcinoma
    Greten, TF
    Ormandy, L
    Manns, MP
    Korangy, F
    HEPATOLOGY, 2005, 42 (04) : 380A - 380A
  • [6] Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma
    Butsch, Raphael
    Waelti, Stephan Lukas
    Schaerer, Sarah
    Braun, Julia
    Korol, Dimitri
    Probst-Hensch, Nicole
    Moch, Holger
    Kurrer, Michael
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1230 - 1238
  • [7] The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma
    Coca, S
    PerezPiqueras, J
    Martinez, D
    Colmenarejo, A
    Saez, MA
    Vallejo, C
    Martos, JA
    Moreno, M
    CANCER, 1997, 79 (12) : 2320 - 2328
  • [8] Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
    Zheng-Jun Zhou
    Hao-Yang Xin
    Jia Li
    Zhi-Qiang Hu
    Chu-Bin Luo
    Shao-Lai Zhou
    Cancer Immunology, Immunotherapy, 2019, 68 : 1223 - 1233
  • [9] Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
    Zhou, Zheng-Jun
    Xin, Hao-Yang
    Li, Jia
    Hu, Zhi-Qiang
    Luo, Chu-Bin
    Zhou, Shao-Lai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (08) : 1223 - 1233
  • [10] Impact of intratumoral mature dendritic cells on prognosis of the patients with esophageal squamous cell carcinoma
    Nishimura, Junya
    Tanaka, Hiroaki
    Miki, Yuichiro
    Tamura, Tatsuro
    Fukuoka, Tatsunari
    Ohira, Go
    Shibutani, Masatsune
    Yamazoe, Sadaaki
    Kimura, Kenjiro
    Toyokawa, Takahiro
    Nagahara, Hisashi
    Amano, Ryosuke
    Muguruma, Kazuya
    Maeda, Kiyoshi
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER RESEARCH, 2017, 77